Enzyvant Sciences Company
Enzyvant Sciences is a biotechnology company that specializes in developing treatments for rare diseases, with a focus on regenerative medicine, immunology, and cardiopulmonology. The company aims to improve the health of people by addressing patient needs in various areas, including psychiatry, oncology, urology, women's health, rare diseases, and cell & gene therapy. Enzyvant primarily serves the healthcare sector and is dedicated to meeting the needs of the rare disease community.
Employee Number:
51-100
Headquarters:
Basel, Switzerland
Estimated Revenue:
2.3B
Industry:
Biotechnology